Impact on outcomes of human leukocyte antigen matching by allele-level typing in adults with acute myeloid leukemia undergoing umbilical cord blood transplantation
Jaime Sanz, Francisco J Jaramillo, Dolores Planelles, Pau Montesinos, Ignacio Lorenzo, Federico Moscardó, Guillermo Martin, Francisca López, Jesús Martínez, Isidro Jarque, Javier de la Rubia, Luis Larrea, Miguel A Sanz, Guillermo F Sanz, Jaime Sanz, Francisco J Jaramillo, Dolores Planelles, Pau Montesinos, Ignacio Lorenzo, Federico Moscardó, Guillermo Martin, Francisca López, Jesús Martínez, Isidro Jarque, Javier de la Rubia, Luis Larrea, Miguel A Sanz, Guillermo F Sanz
Abstract
This retrospective study analyzed the impact of directional donor-recipient human leukocyte antigen (HLA) disparity using allele-level typing at HLA-A, -B, -C, and -DRB1 in 79 adults with acute myeloid leukemia (AML) who received single-unit umbilical cord blood (UCB) transplant at a single institution. With extended high-resolution HLA typing, the donor-recipient compatibility ranged from 2/8 to 8/8. HLA disparity showed no negative impact on nonrelapse mortality (NRM), graft-versus-host (GVH) disease or engraftment. Considering disparities in the GVH direction, the 5-year cumulative incidence of relapse was 44% and 22% for patients receiving an UCB unit matched ≥ 6/8 and < 6/8, respectively (P = .04). In multivariable analysis, a higher HLA disparity in the GVH direction using extended high-resolution typing (Risk ratio [RR] 2.8; 95% confidence interval [CI], 1.5 to 5.1; P = .0009) and first complete remission at time of transplantation (RR 2.1; 95% CI, 1.2 to 3.8; P = .01) were the only variables significantly associated with an improved disease-free survival. In conclusion, we found that in adults with AML undergoing single-unit UCBT, an increased number of HLA disparities at allele-level typing improved disease-free survival by decreasing the relapse rate without a negative effect on NRM.
Source: PubMed